Nano-vectors for efficient liver specific gene transfer

International Journal of Nanomedicine

Volumn 3, Issue 1, 2008, Pages 31-49

  Pathak, Atul ^a   Vyas, Suresh P ^b   Gupta, Kailash C ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

Asialoglycoprotein receptors; Hepatocytes; Liposomes; Nanoparticles; Nucleic acids

Indexed keywords

ANTIBODY; ANTISENSE OLIGODEOXYNUCLEOTIDE; ASIALOCERULOPLASMIN; ASIALOFETUIN; ASIALOGLYCOPROTEIN RECEPTOR; ASIALOLACTOFERRIN; ASIALOOROSOMUCOID; ASIALOTRANSFERRIN; CHITOSAN; CHOLESTEN 5 YLOXY N [4 [[(1 IMINO 2 B DEXTRO THIOGALACTOSYLETHYL)AMINO]BUTYL]FORMAMIDE; CHOLESTEROL DERIVATIVE; DISTEAROYL LEVO PHOSPHATIDYLCHOLINE; DNA; GALACTOSE; GALACTOSYLATED CHOLESTEROL DERIVATIVE; GLOBULIN; GLYCOPROTEIN; HEPATOGLOBULIN; LACTOSE; LIPOPLEX; LIPOSOME; NANOCARRIER; PHOSPHORUS; POLYETHYLENEIMINE; POLYLYSINE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; DNA TRANSFECTION; DRUG HALF LIFE; DRUG STABILITY; DRUG TARGETING; ENDOTHELIUM CELL; GASTROINTESTINAL TRACT; GENE DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; LIPOSOMAL GENE DELIVERY SYSTEM; LIVER DISEASE; LIVER METABOLISM; LIVER PARENCHYMA; NONHUMAN; REVIEW; TRANSGENE;

ANIMALS; DRUG CARRIERS; GENE THERAPY; GENETIC VECTORS; HUMANS; LIVER; LIVER DISEASES; NANOSTRUCTURES; TRANSFECTION;

EID: 66449094611     PISSN: 11769114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Akhtar S, Hughes M, Khan A, et al. 2000. The delivery of antisense therapeutics. Adv Drug Deliv Rev, 44:3-21.
2. Arangoa MA, Duzgunes N, Tros de Ilarduya C. 2003. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes. Gene Ther, 10:5-14.
3. Azzam T, Domb AJ. 2004. Current developments in gene transfection agents. Curr Drug Deliv, 1:165-93.
4. Bartsch M, Weeke-Klimp AH, Hoenselaar EP, et al. 2004. Stabilized lipid coated lipoplexes for the delivery of antisense oligonucleotides to liver endothelial cells in vitro and in vivo. J Drug Target, 12:613-21.
5. Bettinger T, Remy JS, Erbacher P. 1999. Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes. Bioconjug Chem, 10:558-61.
6. Bondi ML, Azzolina A, Craparo EF, et al. 2007. Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery. J Drug Target, 15:295-301.
7. Chen CP, Kim JS, Liu D, et al. 2007. Synthetic PEGylated glycoproteins and their utility in gene delivery. Bioconjug Chem, 18:371-8.
8. Choi YH, Liu F, Park JS, et al. 1998. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-targeted gene carrier. Bioconjug Chem, 9:708-18.
9. Choi YH, Liu F, Choi JS, et al. 1999. Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine and its complex with plasmid DNA. Hum Gene Ther, 10:2657-65.
10. Choi BY, Chung JW, Park JH, et al. 2002. Gene delivery to the rat liver using cationic lipid emulsion/DNA complex: comparison between intra-arterial, intraportal and intravenous administration. Korean J Radiol, 3:194-8.
11. Conner SD, Schmid SL. 2003. Regulated portals of entry into the cells. Nature. 422:37-43.
12. Cook SE, Park IN, Kim EM, et al. 2005. Galactosylated polyethylenimine-graft-poly(vinyl pyrrolidone) as a hepatocyte-targeting gene carrier. J Control Rel, 105:151-63.
13. Crystal RG. 1995. Transfer of genes to human: early lessons and obstacles to success. Science, 270:404-10.
14. Dai H, Jiang X, Tan GC, et al. 2006. Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery. Int J Nanomed, 1:507-522.
15. Elouahabi A, Ruysschaert JM. 2005. Formation and intracellular trafficking of lipoplexes and polyplexes. Mol Ther, 11:336-47.
16. Erbacher P, Roche AC, Monsigny M, et al. 1996. Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA/ lactosylated polylysine complexes. Exp Cell Res, 225:186-94.
17. Felgner PL, Barenholz Y, Behr J-P, et al. 1997. Nomenclature for synthetic gene delivery systems. Hum Gene Ther, 20:511-12.
18. Felt O, Buri P, Gurny R. 1998. Chitosan: a unique polysaccharide for drug delivery. Drug DevInd Pharm, 24:979-93.
19. Fuhrer C, Geffen I, Huggel K, et al. 1994. The two subunits of the asialoglycoprotein receptor contain different sorting information. J Biol Chem, 269:3277-82.
20. Fumoto S, Kawakami S, Ito Y, et al. 2004. Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/ plasmid DNA complex using sodium chloride for complex formation. Mol Ther, 10:719-29.
21. Gao S, Chen J, Xu X, et al. 2003. Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. Int J Pharm, 255:57-68.
22. Gao S, Chen J, Dong L, et al. 2005. Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector. Eur J Pharm Biopharm, 60:327-34.
23. Garcia L, Bunuales M, Duzgunes N, et al. 2007. Serum-resistant lipopolyplexes for gene delivery to liver tumor cells. Eur J Pharm Biopharm, 67:58-66.
24. Geuze HJ, Slot JW, Strous GJ, et al. 1982. Immunocytochemical localization of the receptor for asialoglycoprotein in rat liver cells. J Cell Biol, 92:865-70.
25. Ghosh YK, Visweswariah SS, Bhattacharya S. 2000. Nature of linkage between the cationic headgroup and cholesteryl skeleton controls gene transfection efficiency. FEBS Lett, 473:341-4.
26. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. 2003. LMO2-associated clonal T-cell proliferation in two patients after gene therapy for SCID-X1. Science, 302:400-1.
27. Haensler J, Szoka FC Jr. 1993. Synthesis and characterization of a trigalactosylated bisacridine compound to target DNA to hepatocytes. Bioconjug Chem, 4:85-93.
28. Hasegawa T, Umeda M, Matsumoto T, et al. 2004. Lactose-appended schizophyllan is a potential candidate as a hepatocyte-targeted antisense carrier. Chem Commun (Camb), 21:382-3.
29. Hashida M, Nishikawa M, Yamashita F, et al. 2001. Cell-specific delivery of genes with glycosylated carriers. Adv Drug Deliv Rev, 52:187-96.
30. Hosseinkhani H, Aoyama T, Ogawa O, et al. 2002. Liver targeting of plasmid DNA by pullulan conjugation based on metal coordination. J Control Rel, 83:287-302.
31. Horiuchi S, Aoyama Y. 2006. Systematic lactose-functionalization of amphiphilic octaamine macrocycle as a gene carrier. Optimization of the charge, size, toxicity, and receptor factors for hepatocyte targeting. J Control Rel, 116:107-14.
32. Hwang SH, Hayashi K, Takayama K, et al. 2001. Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes. Gene Ther, 8:1276-80.
33. Illum L. 1998. Chitosan and its use as a pharmaceutical excipient. Pharm Res, 15:1326-31.
34. Jiang JW, Zhang Y. 2004. Targeting delivery effect of galactose receptor-mediated c-myc antisense oligonucleotide on human hepatocellular carcinoma cell line Bel-7402. Chinese J Cancer, 23:1288-93.
35. Kamruzzaman Selim KM, Ha YS, Kim SJ, et al. 2007. Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes. Biomaterials, 28:710-16.
36. Karinaga R, Anada T, Minari J, et al. 2006. Galactose-PEG dual conjugation of beta-(1-3)-D-glucan schizophyllan for antisense oligonucleotides delivery to enhance the cellular uptake. Biomaterials, 27:1626-35.
37. Kawakami S, Yamashita F, Nishikawa M, et al. 1998. Asialoglycoprotein receptor mediated gene transfer using novel galactosylated cationic liposomes Biochem Biophy Res Commun, 252:78-83.
38. Kawakami S, Fumoto S, Nishikawa M, et al. 2000. In vivo gene delivery to the liver using galactosylated cationic liposomes. Pharm Res, 17:306-13.
39. Kawakami S, Yamashita F, Nishida K, et al. 2002. Glycosylated cationic liposomes for cell-selective gene delivery. Crit Rev Ther Drug Carrier Syst, 19:171-90.
40. Kim TH, Park IK, Nah JW, et al. 2004. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. Biomaterials, 25:3783-92.
41. Kim TH, Kim SI, Akaike T, et al. 2005. Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes. J Control Rel, 105:354-66.
42. Kwoh DY, Coffin CC, Lollo CP, et al. 1999. Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver. Biochim Biophys Acta, 1444:171-90.
43. Kunath K, von Harpe A, Fischer D, et al. 2003. Galactose-PEI-DNA complexes for targeted gene delivery: degree of substitution affects complex size and transfection efficiency. J Control Rel, 88:159-72.
44. Leclercq F, Dubertret C, Pitard B, et al. 2000. Synthesis of glycosylated polyethylenimine with reduced toxicity and high transfecting efficiency. Bioorg Med Chem Lett, 10:1233-5.
45. Lim DW, Yeom YI, Park TG. 2000. Poly(DMAEMA-NVP)-b-PEG-galactose as gene delivery vector for hepatocytes. Bioconjug Chem, 11:688-95.
46. Liu F, Park JS, Choi Y-H. 2001. Hepatocyte targeting polyethylene glycografted poly-L-lysine polymeric gene carrier. United States Patent 6177274.
47. Managit C, Kawakami S, Yamashita F, et al. 2005. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes. J Pharm Sci, 94:2266-75.
48. Mao SJ, Hou SX, He R, et al. 2005. Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes. World J Gastroenterol, 11:3075-9.
49. Martinez-Fong D, Mullersman JE, Purchio AF, et al. 1994. Nonenzymatic glycosylation of poly-L-lysine: a new tool for targeted gene delivery. Hepatology, 20:1602-8.
50. Matsuura S, Nakada H, Sawamura T, et al. 1982. Distribution of an asialoglycoprotein receptor on rat hepatocyte cell surface. J Cell Biol, 95:864-75.
51. Midoux P, Mendes C, Legrand A, et al. 1993. Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells. Nucleic Acids Res, 21:871-8.
52. Mitsuru H, Shigeo T, Makiya N, et al. 1998. Targeted delivery of plasmid DNA complexed with galactosylatedpoly(L-lysine). J Control Rel, 53:301-10.
53. Morimoto K, Nishikawa M, Kawakami S, et al. 2003. Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver. Mol Ther, 7:254-61.
54. Murao A, Nishikawa M, Managit C, et al. 2002. Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: Effect of lipid composition. Pharm Res, 19:1808-14.
55. Nagaoka T, Fukuda T, Yoshida S, et al. 2007. Characterization of bio-nanocapsule as a transfer vector targeting human hepatocyte carcinoma by disulfide linkage modification. J Control Rel, 118:348-56.
56. Nishikawa M, Huang L. 2001. Nonviral vectors in the new millennium: delivery barrier in gene transfer. Hum Gene Ther, 12:861-70.
57. Nishikawa M, Kawakami S, Yamashita F, et al. 2003. Glycosylated cationic liposomes for carbohydrate receptor-mediated gene transfer. Methods Enzymol, 373:384-99.
58. Oh ST, Rih JK, Kwon HS, et al. 1997. Lactoferrin as a gene delivery vehicle to hepatocytes. Exp Mol Med, 29:111-16.
59. Panyam J, Zhou WZ, Prabha S, et al. 2002. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J, 16:1217-26.
60. Park TG, Jeong JH, Kim SW. 2006. Current status of polymeric gene delivery systems. Adv Drug Deliv Rev, 58:467-86.
61. Park YH, Park YH, Shin BA, et al. 2000. Galactosylated chitosan - graft - dextran as hepatocyte-targeting DNA carrier. J Control Rel, 69:97-108.
62. Park IK, Kim TH, Park YH, et al. 2001. Galactosylated chitosan-graft-poly(ethylene glycol) as hepatocyte-targeting DNA carrier. J Control Rel, 76:349-62.
63. Park IK, Ihm JE, Park YH, et al. 2003. Galactosylated chitosan (GC)-graft-poly(vinyl pyrrolidone) (PVP) as hepatocyte-targeting DNA carrier. Preparation and physicochemical characterization of GC-graft-PVP/DNA complex (1). J Control Rel, 86:349-59.
64. Pathak A, Aggarwal A, Kurupati RK, et al. 2007. Engineered polyallylamine nanoparticles for efficient in vitro transfection. Pharm Res, 24:1427-40.
65. Reinis M, Damková M, Korec F. 1993. Receptor-mediated transport of oligodeoxynucleotides into hepatic cells. J Virol Methods, 42:99-105.
66. Satoh T, Kakimoto S, Kano H, et al. 2007. In vitro gene delivery to HepG2 cells using galactosylated 6-amino-6-deoxychitosan as a DNA carrier. Carbohydr Res, 342:1427-33.
67. Scherphof GL, Koning G, Bartsch M, et al. 2002. Targeting liposomes and lipoplexes to cells in the liver. Cell Mol Biol Lett, 7:251-4.
68. Schneider DB, Sassani AB, Vassalli G, et al. 1999. Adventitial delivery minimizes the proinflammatory effects of adenoviral vectors. J Vasc Surg, 29:543-50.
69. Shimada K, Kamps JAAM, Regts J, et al. 1997. Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(ethyleneglycol)s. Biochimica Biophysica Acta - Biomembranes, 1326:329-41.
70. Sihorkar V, Vyas SP. 2001. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. J Pharm Pharmaceuti Sci, 4:138-58.
71. Stockert RJ. 1995. The asialoglycoprotein receptor: relations between structure, function and expression. Physiol Rev, 75:591-609.
72. Sun X, Hai L, Wu Y, et al. 2005. Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD). J Drug Target, 13:121-8.
73. Takei Y, Maruyama A, Ferdous A, et al. 2004. Targeted gene delivery to sinusoidal endothelial cells: DNA nanoassociate bearing hyaluronan-glycocalyx. FASEB J, 18:699-701.
74. Tanaka T, Fujishima Y, Hanano S, et al 2004. Intracellular disposition of polysaccharides in rat liver parenchymal and nonparenchymal cells. Int J Pharma, 286:9-17.
75. Van Rossenberg SM, Sliedregt-Bol KM, Meeuwenoord NJ, et al. 2002. Targeted lysosome disruptive elements for improvement of parenchymal liver cell-specific gene delivery. J Biol Chem, 277:45803-10.
76. Wall DA, Hubbard AL. 1981. Galactose-specific recognition system of mammalian liver: receptor distribution on the hepatocyte cell surface. J Cell Biol, 90:687-96.
77. Wang XH, Wang SQ, Wen SY, et al. 2001. The inhibitory effects of hepatocyte targeting pH-sensitive liposome mediated phosphorothioate antisense oligonucleotide on gene expression controlled by HCV 5′NCR. Sheng Wu Gong Cheng Xue Bao, 1:626-30.
78. Wang J, Gao SJ, Zhang PC, et al. 2004. Polyphosphoramidate gene carriers: effect of charge group on gene transfer efficiency. Gene Ther, 11:1001-10.
79. Wen S-Y, Wang X-H, Lin L, et al. 2004. Preparation and property analysis of a hepatocyte targeting pH-sensitive liposome. World J Gastroenterol, 10:244-9.
80. Wong SC, Wakefield D, Klein J, et al. 2006. Hepatocyte targeting of nucleic acid complexes and liposomes by a T7 phage p17 peptide. Mol Pharm, 3:386-97.
81. Wu J, Wu G, Zerm M.1998. The prospects of hepatic drug delivery and gene therapy. Exp Opin Invest Drug, 7:1795-817.
82. Yang CQ, Wang JY, He BM, et al. 2000. Glyco-poly-l-lysine is better than liposomal delivery of exogenous genes to rat of liver. World J Gastroenterol, 6:526-31.
83. Zhang XQ, Wang XL, Zhang PC, et al. 2005. Galactosylated ternary DNA/ polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes. J Control Rel, 102:749-63.